GlaxoSmithKline has failed to gain approval from the Food and Drug Administration for an extended release version of its epilepsy drug Lamictal, according to Bloomberg.com. Newspaper links Pittsburgh pharmacy industry to change in prescription policy FDA bill currently in consideration to regulate prescription drug advertising NACDS' Industry Profile reports on retail pharmacy numbers Longs Drugs to provide flu vaccines this season Lornamead announces winners in model contest Pur-lisse skin care line introduced nationwide Building new bridges to e-prescribing, SureScripts turns to vendors for advice Warner Chilcott sues Barr over patent BMS to acquire biologics developer for $430 million First Previous 2676 2677 2678 2679 2680 Next Last